Robert Laing

7.6k total citations
81 papers, 2.1k citations indexed

About

Robert Laing is a scholar working on Pulmonary and Respiratory Medicine, Urology and Oncology. According to data from OpenAlex, Robert Laing has authored 81 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 14 papers in Urology and 12 papers in Oncology. Recurrent topics in Robert Laing's work include Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (31 papers) and Urinary Bladder and Prostate Research (13 papers). Robert Laing is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (35 papers), Prostate Cancer Treatment and Research (31 papers) and Urinary Bladder and Prostate Research (13 papers). Robert Laing collaborates with scholars based in United Kingdom, Singapore and United States. Robert Laing's co-authors include Stephen Langley, Alastair Henderson, M. Brada, A.P. Warrington, Rodney J. Laing, Jan Jakubowski, Frances Hines, Alan P. Warrington, Michael Brada and Peter Hoskin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Stroke.

In The Last Decade

Robert Laing

79 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Laing United Kingdom 26 1.3k 370 367 335 319 81 2.1k
Mark V. Mishra United States 25 972 0.7× 324 0.9× 365 1.0× 313 0.9× 418 1.3× 145 2.1k
Natia Esiashvili United States 27 965 0.7× 354 1.0× 534 1.5× 314 0.9× 259 0.8× 112 2.5k
Angelo Bolognesi Italy 22 1.1k 0.8× 179 0.5× 413 1.1× 365 1.1× 575 1.8× 64 1.9k
P. Rubin United States 28 1.0k 0.8× 692 1.9× 419 1.1× 625 1.9× 305 1.0× 83 2.5k
Thomas Zilli Switzerland 28 1.9k 1.4× 143 0.4× 408 1.1× 847 2.5× 791 2.5× 182 2.7k
Geert O. Janssens Netherlands 26 718 0.5× 515 1.4× 308 0.8× 419 1.3× 364 1.1× 127 2.1k
Chia‐Hsien Chang Taiwan 16 590 0.4× 880 2.4× 192 0.5× 313 0.9× 80 0.3× 28 1.6k
Richard Holý Germany 28 1.3k 1.0× 474 1.3× 180 0.5× 911 2.7× 996 3.1× 71 2.1k
A. Gabriella Wernicke United States 24 764 0.6× 564 1.5× 401 1.1× 324 1.0× 209 0.7× 112 1.7k
Seung Do Ahn South Korea 31 1.3k 1.0× 183 0.5× 959 2.6× 726 2.2× 753 2.4× 158 3.1k

Countries citing papers authored by Robert Laing

Since Specialization
Citations

This map shows the geographic impact of Robert Laing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Laing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Laing more than expected).

Fields of papers citing papers by Robert Laing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Laing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Laing. The network helps show where Robert Laing may publish in the future.

Co-authorship network of co-authors of Robert Laing

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Laing. A scholar is included among the top collaborators of Robert Laing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Laing. Robert Laing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uribe‐Lewis, Santiago, Christos Mikropoulos, Sophie Otter, et al.. (2021). Long‐term survival after low‐dose‐rate brachytherapy for prostate cancer: the Royal Surrey experience. British Journal of Urology. 129(6). 723–730. 2 indexed citations
2.
Langley, Stephen, Christopher Eden, Matthew Perry, et al.. (2021). Robot‐assisted salvage seminal vesicle excision for isolated recurrence after low‐dose‐rate prostate brachytherapy. British Journal of Urology. 129(6). 731–736. 4 indexed citations
3.
Langley, Stephen, et al.. (2019). Hemi‐ablative low‐dose‐rate prostate brachytherapy for unilateral localised prostate cancer. British Journal of Urology. 125(3). 383–390. 13 indexed citations
4.
Laing, Robert, et al.. (2018). Low‐dose‐rate brachytherapy for the treatment of localised prostate cancer in men with a high risk of disease relapse. British Journal of Urology. 122(4). 610–617. 6 indexed citations
5.
Langley, Stephen, et al.. (2017). Long‐term oncological outcomes and toxicity in 597 men aged ≤60 years at time of low‐dose‐rate brachytherapy for localised prostate cancer. British Journal of Urology. 121(1). 38–45. 22 indexed citations
6.
7.
8.
Laing, Robert, et al.. (2016). Hemi-gland focal low dose rate prostate brachytherapy: An analysis of dosimetric outcomes. Radiotherapy and Oncology. 121(2). 310–315. 16 indexed citations
9.
Stewart, Alexandra, K. Drinkwater, Robert Laing, Jenny Nobes, & Imogen Locke. (2015). The Royal College of Radiologists' Audit of Prostate Brachytherapy in the Year 2012. Clinical Oncology. 27(6). 330–336. 8 indexed citations
10.
Ring, Alistair, Duncan Wheatley, Helen Hatcher, et al.. (2014). Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer. Clinical Cancer Research. 21(12). 2737–2744. 16 indexed citations
11.
Earley, James J., et al.. (2012). Correlation between prostate brachytherapy-related urethral stricture and peri-apical urethral dosimetry: A matched case–control study. Radiotherapy and Oncology. 104(2). 187–191. 27 indexed citations
12.
Sooriakumaran, Prasanna, Stephen Langley, Robert Laing, & Helen M. Coley. (2007). COX-2 Inhibition: A Possible Role in the Management of Prostate Cancer?. Journal of Chemotherapy. 19(1). 21–32. 18 indexed citations
13.
Sooriakumaran, Prasanna, Patricia Macanas-Pirard, Stephen Langley, et al.. (2006). The COX-2 inhibitor celecoxib and its use in the management of prostate cancer.. Cancer Research. 66. 1239–1239. 1 indexed citations
14.
Guedea, Ferrán, Ferrán Aguiló, Alfredo Polo, et al.. (2006). Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1–T2 prostate cancer. Radiotherapy and Oncology. 80(1). 57–61. 33 indexed citations
15.
Henderson, Alastair, et al.. (2003). Toxicity and Early Biochemical Outcomes From 125Iodine Prostate Brachytherapy in the U.K.. Clinical Oncology. 16(2). 95–104. 35 indexed citations
16.
Langley, Stephen & Robert Laing. (2002). Prostate brachytherapy has come of age: a review of the technique and results. British Journal of Urology. 89(3). 241–249. 50 indexed citations
17.
Landau, David & Robert Laing. (2000). An Audit of Indications and Techniques for Supraclavicular Fossa Irradiation in Early Breast Cancer in the United Kingdom. Clinical Oncology. 12(3). 172–178. 5 indexed citations
18.
Brada, M. & Robert Laing. (1994). Radiosurgery/Stereotactic External Beam Radiotherapy for Malignant Brain Tumours: The Royal Marsden Hospital Experience. Recent results in cancer research. 135. 91–104. 16 indexed citations
19.
Laing, Robert, A.P. Warrington, Frances Hines, John D. Graham, & M. Brada. (1993). Fractionated stereotactic external beam radiotherapy in the management of brain metastases. European Journal of Cancer. 29(10). 1387–1391. 20 indexed citations
20.
Laing, Robert, Alan P. Warrington, John D. Graham, et al.. (1993). Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiotherapy and Oncology. 27(1). 22–29. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark V. Mishra Breakdown of academic impact, for papers by Natia Esiashvili Breakdown of academic impact, for papers by Angelo Bolognesi Breakdown of academic impact, for papers by P. Rubin Breakdown of academic impact, for papers by Thomas Zilli Breakdown of academic impact, for papers by Geert O. Janssens Breakdown of academic impact, for papers by Chia‐Hsien Chang Breakdown of academic impact, for papers by Richard Holý Breakdown of academic impact, for papers by A. Gabriella Wernicke Breakdown of academic impact, for papers by Seung Do Ahn
Rankless by CCL
2026